E2F1 protein levels were depleted with valproic acid exposure in prostate cancer cell lines and valproic acid reduced E2F1 binding to the BRCA1 promoter, thus providing insight into a mechanism for the down regulation of the BRCA1 gene by HDAC inhibition. The gene discussed is HDAC9; the disease is prostate cancer.